AI
CMD

Atom Investors’s Cantel Medical Corporation CMD Stock Holding History

Atom Investors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,844
Closed -$361K – 760
2018
Q4 		$361K Buy
+4,844
New +$400K 0.04% 454

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Atom Investors's CMD Position: Q1 2019 in Review

Atom Investors sold out of Cantel Medical Corporation (CMD) in Q1 2019, closing a stake of 4,844 shares — an estimated $361K sold.

Atom Investors first reported a position in CMD in Q4 2018 and held it in 1 quarter. The position peaked at $361K in Q4 2018. 254 funds tracked by Wall St. Rank hold CMD as of Q1 2019.

  • Atom Investors reported no remaining Cantel Medical Corporation position as of Q1 2019 after selling out during the quarter.
  • Atom Investors sold 4,844 Cantel Medical Corporation shares in Q1 2019, an estimated $361K.
  • Atom Investors first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 1 quarter.
  • Atom Investors's Cantel Medical Corporation position peaked at $361K in Q4 2018.
  • 254 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2019.

Based on Atom Investors's 13F filing for Q1 2019, filed 15 May 2019.